Signup/Login
If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
Signup/Login
Can you determine which companies are good and which ones - the trash?
Free Pro-version
IPO Filter
Monitor
IPO today
Upcoming IPO
Priced IPO
Solaredge Technologies, Inc. (SEDG)
The Marygold Companies (MGLD)
Blue Water Vaccines (BWV)
Meihua International Medical Technologies (MHUA)
Smart for Life (SMFL)
Vivakor (VIVK)
TC BioPharm Holdings (TCBP)
Direct Digital Holdings, Llc (DRCT)
Modiv (MDV)
Sky Technologies (SKYX)
Modular Medical (MODD)
HeartCore Enterprises (HTCR)
Arcellx, Inc. (ACLX)
Silver Spike Investment Corp. (SSIC)
Maris-Tech Ltd. (MTEK)
Yoshitsu Co., Ltd. (TKLF)
Tpg Inc. (TPG)
Hillstream BioPharma (HILS)
Hour Loop (HOUR)
Vigil Neuroscience, Inc. (VIGL)
More companies

TLGY Acquisition (TLGY.U)

Sector - SPAC

Price chart

-100%
Return from IPO

Last SPACs News

IPO Profile

About company

They are a newly incorporated blank check company. While they may pursue an acquisition opportunity in any business, industry, sector, or geographical location, they intend to focus on targets in industries where they believe their management team and their founder’s expertise will provide them with a competitive advantage, including biopharma or technology enabled business-to-consumer (“B2C”) industries globally. They believe the innovations in these sectors that have emerged in recent years, partly as a response to the broad social, economic, and behavioral changes arising from the COVID-19 global pandemic, provide attractive opportunities to target high growth companies with technology and business model innovation. For example, by virtue of their team’s industry network and their founder’s recent investments, they have turned their attention towards certain sub-segments in healthcare, including neurology and rare diseases, where they believe they can find attractive targets for their business combination. While they will target companies globally, they believe that their team’s strong ties to Asia gives them an advantage in sourcing Asia-originated biopharma companies with global aspirations for the purposes of a business combination in the U.S. market. They believe favorable innovation and regulatory trends in Asia should position them well for such opportunities.
CEO CFO
-
Employees Founded
3 2021

Contacts

Web page:

IPO information

First Trade Date 12/1/2021
Status Priced
Exchange NASDAQ
Lockup Period Expiration .Pro
Quiet Period Expiration .Pro
Old Price Range
-
Share prices ($)

Shares & Volumes

Shares Initial (MM) 17.5
Shares Revised (MM) 20
Expected offer amount (MM) $175
Realized offer amount(MM) $200

Financial Data (last reporting year)

Market Cap (MM) -
Revenues (MM) -
Net Income (Loss) (MM) -

Voting

What do you think will happen with the TLGY.U share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)

Number of votes: img
Underwriters
Mizuho Securities
CO-Managers
Baird